Prognostic relevance of increased Rac GTPase expression in prostate carcinomas
| Autor: | Rainer Engers, R. Willers, A Walter, H. E. Gabbert, S Ziegler, Mirko Mueller |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
PCA3
Male rac1 GTP-Binding Protein Cancer Research Pathology medicine.medical_specialty Endocrinology Diabetes and Metabolism Immunoblotting Rac3 RAC1 Biology Disease-Free Survival Metastasis Prostate cancer Endocrinology Prostate medicine Humans Protein Isoforms RNA Messenger Aged Carcinoma Prostatic Neoplasms Middle Aged medicine.disease Prognosis rac GTP-Binding Proteins Rac GTP-Binding Proteins medicine.anatomical_structure Oncology Cancer research Immunohistochemistry |
| Zdroj: | Endocrine-related cancer. 14(2) |
| ISSN: | 1351-0088 |
| Popis: | Rac proteins of the Rho-like GTPase family, including the ubiquitous Rac1, the hematopoiesis-specific Rac2, and the least-characterized Rac3 play a major role in oncogenic transformation, tumor invasion and metastasis. However, the prognostic relevance of Rac expression in human tumors has not been investigated yet. In the present study, Rac protein expression was analyzed in benign secretory epithelium, high-grade prostatic intraepithelium neoplasia (HG-PIN), and prostate carcinomas of 60 R0-resected radical prostatectomy specimens by semiquantitative immunohistochemistry. Thus, Rac proteins were significantly strongly expressed in HG-PIN (P < 0.001) and prostate carcinomas (P < 0.001) when compared with benign secretory epithelium. Accordingly, all tumor tissues analyzed by isoform-specific real-time PCR (n = 7) exhibited significantly higher RNA expression levels of Rac (i.e. sum of Rac1 and Rac3 expression levels) than the respective benign counterparts (P = 0.018) and this appeared to result mainly from increased expression of the Rac3 isoform as verified by immunoblotting. Univariate analyses showed statistically significant associations of increased Rac protein expression in prostate cancer (P = 0.045), preoperative prostate-specific antigen levels (P = 0.044), pT stage (P = 0.002), and Gleason score (P = 0.001) with decreased disease-free survival (DFS). This prognostic effect of increased protein expression of Rac remained significant even in a multivariate analysis including all these four factors (relative risk = 3.22, 95% confidence interval = 1.04–10.00; P = 0.043). In conclusion, our data suggest that increased Rac protein expression in prostate cancer relative to the corresponding benign secretory epithelium is an independent predictor of decreased DFS and appears to result mainly from increased expression of the Rac3 isoform. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|